article thumbnail

TAVI Matches SAVR in Lower Risk Aortic Valve Patients: 10 year outcomes

Cardiology Update

The NOTION trial, a pioneering study, sought to compare the long-term clinical and bioprosthesis outcomes of Transcatheter Aortic Valve Implantation (TAVI) versus Surgical Aortic Valve Replacement (SAVR) in patients with severe aortic valve stenosis (AS) at lower surgical risk.

article thumbnail

Myocardial infarction due to coronary embolism after mechanical aortic valve replacement: a case report

Journal of Cardiothoracic Surgery

Prosthetic valve thrombosis (PVT) in aortic valve and its complication coronary embolism is a very rare condition. We present a young patient with acute myocardi. Diagnosis and treatment process is challenging.

article thumbnail

Systematic review and meta-analysis of early aortic valve replacement versus conservative therapy in patients with asymptomatic aortic valve stenosis with preserved left ventricle systolic function

Open Heart

Background A quarter of patients with severe aortic stenosis (AS) were asymptomatic, and only a third of them survived at the end of 4 years. Only a select subset of these patients was recommended for aortic valve replacement (AVR) by the current American College of Cardiology/American Heart Association guidelines.

article thumbnail

Progression of aortic stenosis after an acute myocardial infarction

Open Heart

Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. vs –0.04±0.04 cm 2 /m 2 /year; p=0.004).

article thumbnail

Non-dual antiplatelet therapy versus dual antiplatelet therapy prior to transcatheter aortic valve replacement: A systematic review and meta-analysis

Journal of Cardiovascular Pharmacology

Abstract: Transcatheter aortic valve replacement (TAVR) is an interventional procedure performed in patients with severe aortic stenosis and often required perioperative antiplatelet therapy. Most previous studies have focused on antiplatelet therapy following TAVR. Copyright © 2023 Wolters Kluwer Health, Inc.

article thumbnail

Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis

Heart BMJ

Objective The optimal medical therapy after surgical aortic valve replacement (SAVR) for aortic stenosis remains unknown. Methods All patients undergoing SAVR due to aortic stenosis in Sweden 2006–2020 and surviving 6 months after surgery were included.

article thumbnail

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights from the STS/ACC TVT Registry

Circulation: Cardiovascular Interventions

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Circulation: Cardiovascular Interventions, Ahead of Print. Exposure of interest was PVD. Primary outcome was all-cause mortality.